share_log

Redhill Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Empery Asset Management, LP(3.19%),Ryan M. Lane(3.19%), etc.

SEC announcement ·  Jan 8 00:00
Summary by Moomoo AI
RedHill Biopharma Ltd., a biopharmaceutical company, has been the subject of a recent Schedule 13G amendment filing with the Securities and Exchange Commission (SEC) on December 31, 2023. The filing was made by Empery Asset Management, LP, an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, along with its managing members Ryan M. Lane and Martin D. Hoe. The filing indicates that Empery Asset Management, LP holds 647,824 American Depository Shares (ADSs), equivalent to 259,129,600 Ordinary Shares of RedHill Biopharma, issuable upon the exercise of warrants. This represents approximately 3.19% of the company's class of securities. The warrants are subject to a 4.99% ownership blocker, which prevents the full exercise of the warrants if it would result in ownership exceeding this threshold. As a result, the actual number of Ordinary Shares beneficially owned by the reporting persons is less than the number reported. The filing also includes a certification that the securities were not acquired for the purpose of changing or influencing the control of the issuer.
RedHill Biopharma Ltd., a biopharmaceutical company, has been the subject of a recent Schedule 13G amendment filing with the Securities and Exchange Commission (SEC) on December 31, 2023. The filing was made by Empery Asset Management, LP, an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, along with its managing members Ryan M. Lane and Martin D. Hoe. The filing indicates that Empery Asset Management, LP holds 647,824 American Depository Shares (ADSs), equivalent to 259,129,600 Ordinary Shares of RedHill Biopharma, issuable upon the exercise of warrants. This represents approximately 3.19% of the company's class of securities. The warrants are subject to a 4.99% ownership blocker, which prevents the full exercise of the warrants if it would result in ownership exceeding this threshold. As a result, the actual number of Ordinary Shares beneficially owned by the reporting persons is less than the number reported. The filing also includes a certification that the securities were not acquired for the purpose of changing or influencing the control of the issuer.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more